| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.100 | None | 0.962 | 52 | 1 | 1995 | 2019 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
phenotype | 0.100 | None | 0.971 | 34 | 0 | 1997 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
phenotype | 0.100 | None | 1.000 | 22 | 0 | 1998 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.100 | None | 1.000 | 18 | 1 | 2003 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.812 | 16 | 2 | 2005 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 16 | 0 | 2004 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.100 | None | 1.000 | 13 | 1 | 2002 | 2017 | ||||||||
|
single-strand-selective monofunctional uracil-DNA glycosylase 1 | 0.322 | 0.923 | 4.5E-04 |
|
phenotype | 0.100 | None | 1.000 | 13 | 0 | 2017 | 2020 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 2017 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
phenotype | 0.100 | None | 0.900 | 10 | 0 | 1996 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 10 | 0 | 2002 | 2019 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
phenotype | 0.100 | None | 0.900 | 10 | 0 | 1992 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.090 | None | 1.000 | 9 | 0 | 2006 | 2019 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
phenotype | 0.090 | None | 0.556 | 9 | 0 | 1995 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.080 | None | 0.875 | 8 | 0 | 2001 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 2006 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.070 | None | 1.000 | 7 | 0 | 2011 | 2018 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
phenotype | 0.070 | None | 0.857 | 7 | 0 | 2005 | 2019 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
phenotype | 0.070 | None | 1.000 | 7 | 0 | 2009 | 2011 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.060 | None | 0.833 | 6 | 0 | 2011 | 2018 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
phenotype | 0.060 | None | 0.833 | 6 | 0 | 2000 | 2018 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2008 | 2017 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2006 | 2019 | ||||||||
|
MET transcriptional regulator MACC1 | 0.561 | 0.538 | 6.0E-19 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2011 | 2016 | ||||||||
|
POU class 5 homeobox 1 | 0.441 | 0.846 | 0.95 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2014 | 2018 |